Evidence map›Paper›PMID 41492606›Full record

ArticleCureus2025

Ozone-Induced Encephalopathy Following Subcutaneous Ozone Injection: A Case Report.

Cristiano Gante, Luís Dias

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Cristiano GanteInternal Medicine, Hospital de São José, Unidade Local de Saúde de São José, Lisbon, PRT.
Luís DiasInternal Medicine, Hospital de São José, Unidade Local de Saúde de São José, Lisbon, PRT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ozone therapy has gained popularity as an alternative treatment for various conditions, despite limited scientific evidence supporting its safety and efficacy. Severe neurological complications have been rarely described. We report the case of a previously healthy 55-year-old man who developed acute encephalopathy shortly after a subcutaneous ozone injection. The patient presented to the emergency department with altered mental status, ataxia, and involuntary limb movements. Brain CT was normal, while MRI showed transient cortical diffusion abnormalities. Extensive laboratory and microbiological workup was unremarkable. The patient required mechanical ventilation for 48 hours, after which his neurological symptoms resolved completely without specific therapy. A repeat MRI demonstrated full resolution of the lesions. In the absence of other identifiable causes, a diagnosis of ozone-induced encephalopathy was established. Ozone therapy, although approved for specific indications such as paravertebral or intradiscal administration for radicular pain, may cause serious adverse effects when performed via unsafe routes or under inadequate supervision. This case highlights the potential for severe neurological complications following improper ozone therapy. Medical procedures must adhere to evidence-based indications and strict safety standards to prevent life-threatening outcomes.

Indexed as

altered mental statealternative medical therapiesemergency departmentencephalopathyozone therapy

Identifiers

PMID41492606
PMCPMC12765471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.